Jefferies Group LLC set a $108.00 price objective on Stericycle, Inc. (NASDAQ:SRCL) in a research report released on Tuesday. The firm currently has a buy rating on the business services provider’s stock. Jefferies Group also issued estimates for Stericycle’s Q3 2017 earnings at $1.13 EPS, Q4 2017 earnings at $1.22 EPS, FY2017 earnings at $4.59 EPS and FY2018 earnings at $4.80 EPS.
SRCL has been the topic of a number of other research reports. BidaskClub downgraded shares of Stericycle from a sell rating to a strong sell rating in a research report on Tuesday, August 1st. Zacks Investment Research downgraded shares of Stericycle from a hold rating to a sell rating in a research report on Wednesday, October 4th. William Blair restated an ourperform rating on shares of Stericycle in a research report on Thursday, September 14th. Barclays PLC restated an overweight rating and issued a $100.00 price target on shares of Stericycle in a research report on Wednesday, August 9th. Finally, BMO Capital Markets started coverage on shares of Stericycle in a research report on Thursday, June 29th. They issued a market perform rating and a $81.00 price target on the stock. Four research analysts have rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company. The company presently has a consensus rating of Hold and a consensus price target of $81.25.
Stericycle (NASDAQ SRCL) opened at 72.69 on Tuesday. Stericycle has a one year low of $68.62 and a one year high of $88.00. The company has a 50-day moving average of $71.15 and a 200 day moving average of $77.14. The firm’s market capitalization is $6.20 billion.
Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, August 3rd. The business services provider reported $1.15 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.13 by $0.02. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The firm had revenue of $917.70 million for the quarter, compared to analyst estimates of $902.81 million. During the same period in the previous year, the firm posted $1.18 EPS. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. On average, analysts anticipate that Stericycle will post $4.59 EPS for the current year.
Institutional investors have recently added to or reduced their stakes in the stock. Cipher Capital LP acquired a new position in shares of Stericycle during the 2nd quarter valued at $2,600,000. Stevens Capital Management LP acquired a new position in shares of Stericycle during the 2nd quarter valued at $6,240,000. FNY Managed Accounts LLC acquired a new position in shares of Stericycle during the 2nd quarter valued at $507,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Stericycle by 39.4% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 202,613 shares of the business services provider’s stock valued at $15,463,000 after acquiring an additional 57,314 shares during the period. Finally, Capital Investment Services of America Inc. lifted its position in shares of Stericycle by 3.5% during the 2nd quarter. Capital Investment Services of America Inc. now owns 112,596 shares of the business services provider’s stock valued at $8,593,000 after acquiring an additional 3,825 shares during the period. Institutional investors own 93.54% of the company’s stock.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with our FREE daily email newsletter.